Yigal Koltin
Directeur/Membre du Conseil chez Active P Ltd.
Profil
Yigal Koltin is a professional with a doctorate degree from Harvard University.
He is currently a Director at Active P Ltd., Avraham Pharmaceuticals Ltd., and Accellta Ltd.
He previously held positions as Chairman at Adicet Bio Israel Ltd., Director at Safetek International, Inc., Antisoma, Inc., Solegreen Ltd., and QuantomiX Ltd.
He also served as Vice President-Program Management at Millennium Pharmaceuticals, Inc. and as a Professor at Tel-Aviv University.
Postes actifs de Yigal Koltin
| Sociétés | Poste | Début |
|---|---|---|
Active P Ltd.
 Active P Ltd. Pharmaceuticals: MajorHealth Technology Active P Ltd. develops proprietary oral available peptide drugs to treat diabetes. The company was founded by Shmulik Hess, Chaim Gilon, and Amnon Hoffman on September 10, 2008 and is headquartered in Kiryat Shmona, Israel. | Directeur/Membre du Conseil | 03/03/2010 |
Avraham Pharmaceuticals Ltd.
 Avraham Pharmaceuticals Ltd. BiotechnologyHealth Technology Avraham Pharmaceuticals Ltd. develops pharmaceutical products for prevention and treatment of neurodegenerative disorders. Its lead product candidate, Ladostigil is designed to provide treatment for Mild Cognitive Impairment. The firm’s product candidate is a multifunctional compound that combines neuroprotective mechanisms: reducing oxidative stress and microglial activation, and inhibiting proinflamtory cytokines. The company was founded in 2010 by David Warshawsky and is headquartered in Yavneh, Israel. | Directeur/Membre du Conseil | - |
Accellta Ltd.
 Accellta Ltd. BiotechnologyHealth Technology Accellta Ltd. offers solutions for stem cell culturing. Its portfolio include pluripotent stem cell culturing, human foreskin-derived feeder cells, growth media for feeder-free culturing of hPSC, stem cell expansion in suspension, stem cell culturing as single-cells in bioreactors, stem-cell controlled differentiation, and medium formulation. The company was founded in 2012 and is headquartered in Haifa, Israel. | Directeur/Membre du Conseil | - |
Anciens postes connus de Yigal Koltin
| Sociétés | Poste | Fin |
|---|---|---|
Antisoma, Inc.
 Antisoma, Inc. Pharmaceuticals: MajorHealth Technology Antisoma, Inc. develops drugs and pharmaceuticals. The firm's products include Xanafide, Symadex, and Clomet. Its products are used in clinical and preclinical development for multiple cancer indications. The company was founded in 2001 and is headquartered Cambridge, MA. | Directeur/Membre du Conseil | - |
QuantomiX Ltd.
 QuantomiX Ltd. Pharmaceuticals: MajorHealth Technology QuantomiX Ltd. develops and markets capsules that enable real-time analysis of wet cells and tissue biopsies. The firm with the its QXTM capsule product line, wet samples, including cells and tissues biopsies, will be able to be examined immediately and accurately. The company's technology enables scanning electron microscopes (SEM) to image and analyze wet samples such as cells, tissue biopsies, foods and ink, in their native environment. QuantomiX was founded in March 2001 by Micha Brunstein, Zachy Berger and Ory S. Zik and is headquartered in Rehovot, Israel. | Directeur/Membre du Conseil | - |
| SOLEGREEN | Directeur/Membre du Conseil | - |
Tel-Aviv University
 Tel-Aviv University Other Consumer ServicesConsumer Services Tel-Aviv University operates as a university in Israel. Its faculties include arts, engineering, science, humanities, law, life science, management, medicine, and social science. The company was founded in 1956 and is headquartered in Ramat Aviv, Israel. | Corporate Officer/Principal | - |
Adicet Bio Israel Ltd.
 Adicet Bio Israel Ltd. Pharmaceuticals: MajorHealth Technology Adicet Bio Israel Ltd. develops therapeutic molecules for cancer, viral, and autoimmune diseases. The firm’s technologies include AIT develops a therapeutic antibodies T-Cell Receptor Like. Its TCRL antibodies have diagnostic applications in pathology, vaccine design, validation, and monitoring. The company was founded by Mira Peled-Kamar and Yoram Reiter in 2006 and is headquartered in Haifa, Israel. | Président | - |
Formation de Yigal Koltin
| Harvard University | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| SAFETEK INTERNATIONAL, INC. | Finance |
| SOLEGREEN | Utilities |
| Entreprise privées | 7 |
|---|---|
Millennium Pharmaceuticals, Inc.
 Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Millennium Pharmaceuticals, Inc. operates as a biopharmaceutical company. Its products include Ninlaro and Velcade. The company was founded in 1993 and is headquartered in Cambridge, MA. | Health Technology |
Antisoma, Inc.
Antisoma, Inc. Pharmaceuticals: MajorHealth Technology Antisoma, Inc. develops drugs and pharmaceuticals. The firm's products include Xanafide, Symadex, and Clomet. Its products are used in clinical and preclinical development for multiple cancer indications. The company was founded in 2001 and is headquartered Cambridge, MA. | Health Technology |
QuantomiX Ltd.
QuantomiX Ltd. Pharmaceuticals: MajorHealth Technology QuantomiX Ltd. develops and markets capsules that enable real-time analysis of wet cells and tissue biopsies. The firm with the its QXTM capsule product line, wet samples, including cells and tissues biopsies, will be able to be examined immediately and accurately. The company's technology enables scanning electron microscopes (SEM) to image and analyze wet samples such as cells, tissue biopsies, foods and ink, in their native environment. QuantomiX was founded in March 2001 by Micha Brunstein, Zachy Berger and Ory S. Zik and is headquartered in Rehovot, Israel. | Health Technology |
Active P Ltd.
Active P Ltd. Pharmaceuticals: MajorHealth Technology Active P Ltd. develops proprietary oral available peptide drugs to treat diabetes. The company was founded by Shmulik Hess, Chaim Gilon, and Amnon Hoffman on September 10, 2008 and is headquartered in Kiryat Shmona, Israel. | Health Technology |
Avraham Pharmaceuticals Ltd.
Avraham Pharmaceuticals Ltd. BiotechnologyHealth Technology Avraham Pharmaceuticals Ltd. develops pharmaceutical products for prevention and treatment of neurodegenerative disorders. Its lead product candidate, Ladostigil is designed to provide treatment for Mild Cognitive Impairment. The firm’s product candidate is a multifunctional compound that combines neuroprotective mechanisms: reducing oxidative stress and microglial activation, and inhibiting proinflamtory cytokines. The company was founded in 2010 by David Warshawsky and is headquartered in Yavneh, Israel. | Health Technology |
Adicet Bio Israel Ltd.
Adicet Bio Israel Ltd. Pharmaceuticals: MajorHealth Technology Adicet Bio Israel Ltd. develops therapeutic molecules for cancer, viral, and autoimmune diseases. The firm’s technologies include AIT develops a therapeutic antibodies T-Cell Receptor Like. Its TCRL antibodies have diagnostic applications in pathology, vaccine design, validation, and monitoring. The company was founded by Mira Peled-Kamar and Yoram Reiter in 2006 and is headquartered in Haifa, Israel. | Health Technology |
Accellta Ltd.
Accellta Ltd. BiotechnologyHealth Technology Accellta Ltd. offers solutions for stem cell culturing. Its portfolio include pluripotent stem cell culturing, human foreskin-derived feeder cells, growth media for feeder-free culturing of hPSC, stem cell expansion in suspension, stem cell culturing as single-cells in bioreactors, stem-cell controlled differentiation, and medium formulation. The company was founded in 2012 and is headquartered in Haifa, Israel. | Health Technology |